Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propel DBM
- Development stage
- Unknown
- Lead developer
- NuVasive
- Administration
- Topical
01
Overview
Propel DBM is a demineralized bone matrix (DBM) product line developed by NuVasive (now a part of Globus Medical) for use in spinal fusion and other orthopedic procedures. Classified as a human-derived bone matrix implant, it is used as a bone graft substitute to fill skeletal voids or gaps that are not intrinsic to the stability of the bony structure. The product line includes various form factors such as fibers, gel, and putty, designed to meet different surgical handling requirements. Propel DBM functions through osteoconduction, providing a physical scaffold for new bone growth, and osteoinduction, utilizing the natural growth factors (such as bone morphogenetic proteins) retained within the demineralized matrix to recruit and differentiate mesenchymal stem cells into osteoblasts.
- Brand names
- Propel DBMPropel DBM FibersPropel DBM GelPropel DBM Gel PlusPropel DBM Putty Plus
- Other names
- Demineralized Bone Matrix
02
Targets
BMP (Bone morphogenetic protein family)
Beyond the preview
Go deeper on Propel DBM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Propel DBM.